Canadian generic drugmaker said it would appeal a U.S. court decision that found the patent on Plavix (blood clot preventer) was valid and enforceable. If the federal appeals court should reverse the decision by U.S. District Judge Sidney Stein, Apotex would be able to resume selling generic Plavix. It was ordered to stop shipping the generic Plavix, pending his decision.Monday, July 2, 2007
Apotex to appeal court ruling on Plavix patent
Canadian generic drugmaker said it would appeal a U.S. court decision that found the patent on Plavix (blood clot preventer) was valid and enforceable. If the federal appeals court should reverse the decision by U.S. District Judge Sidney Stein, Apotex would be able to resume selling generic Plavix. It was ordered to stop shipping the generic Plavix, pending his decision.
